Page 5604: under “Results,” in the sentence that begins “Unlike non-CRS indications that received a median of 3.5 doses of emapalumab,” “supplemental Table 2” should read “supplemental Table 1.”
© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
2023
